EGFR and cancer: We hypothesised that cancer-associated fibroblasts (CAF) secrete NRG-1 ligand, which in turn activates cancer cell ErbB3/AKT-mediated signalling, promoting tumourigenesis and rendering EGFR inhibition ineffective.